Testimonials
What they say
Perspectives from teams building with MedOS and leaders across robotics, medtech, and research.
Client testimonies
What our clients say
As we hosted the developers of MedOS at our facility and let them successfully and quickly integrate our SensoRob robot using the state-of-the art Sensodrive joints leading to an Impedance Control demo using the Torque interface, we were amazed to see how rapidly the application was implemented. Leveraging Sensodrive’s advanced joint control algorithms, MedOS with its full suite of software, real-time middleware, algorithms and tools significantly reduces time to market for robotic companies. Moreover, ROS based development and builtin compliance with certification norms, MedOS in collaboration with Sensojoints can truly disrupt the medical robotic industry.
Norbert SporerFounder and CEOSensodrive GmbH, Wessling, GermanyRoboss and MedOS offer a powerful and highly modular software platform for robotic-assisted systems. From our perspective at Vision Engineering, the solution fits seamlessly into advanced imaging and robotics workflows, with strong capabilities in flexibility and real-time data processing. We see clear potential for this platform to accelerate development cycles and significantly reduce technical and integration risks, making it a highly attractive solution for next-generation robotics projects. For us, this plays a key role in enabling future innovation in our robotics initiatives.
Eric MarkwegSenior Technology Manager and Head of Concept TeamVision Engineering, UKWe see strong potential in MedOS to reduce development costs and accelerate time-to-market for medical robotics projects where its capabilities align closely with customer requirements. MedOS could provide a compelling technological and economic advantage, and we are open to integrating and promoting it in suitable future projects.
Dr. Ulrich SutterKey Account Manager, Medical Systems Engineering & RoboticsITK Engineering, GermanyWorking with ROBOSS Pte Ltd, and in particular with its founder Shashank Sharma, has been a very positive experience for us at ARTS GmbH. We highly value robust, application-oriented solutions for mechatronic systems and simulation. ROBOSS has consistently delivered exactly that.
Andreas Wegner-BerndtCo-FounderARTS GmbH, GermanyROBOSS has been a key software partner in Project Atharv, supporting the development of India’s first FDA-certifiable surgical robot. MedOS provides a medical-grade, certifiable software foundation that integrates seamlessly with our custom-developed hardware. Its reliability and flexibility have enabled us to move faster in developing and validating our surgical robotic platform.
Col Dr. Sajal Sen (Retd)AGIHF, Assam, IndiaIndustry
What industry leaders say
Thank you for conducting the Birds of Feather meeting for Medical ROS at ROSCON! I would be willing to support you in case you are interested in leading the global ROS for Medical Foundation as an open source project.
Brian GerkeyCTO, IntrinsicAn Alphabet companyRoboss Pte Ltd is the only partner we’ve seen capable of enabling a fully indigenous, world-class surgical robotics platform at speed, while preserving complete IP control through their MedOS platform.
Dr. Minakshi LateGroup CEO and Global HeadShukra Pharmaceuticals Ltd, IndiaMedOS definitely has the potential to be disruptive. MedOS based applications will massively increase market penetration in RAS (higher ease of use, and lower price).
Thilo Kaltenbach, PhDSenior Partner, HealthcareRoland BergerShashank and his team have something quite interesting here. Too many robotics companies burn too much time and money “reinventing” the wheel when they get into medical robotics. If someone can develop a “turnkey” development platform with key software libraries ready to deploy that are already certified to help with regulatory pathways. Hmmm that’s interesting! When companies get a head start in these fundamental building blocks of the robot - they save time and money and lower the regulatory barriers. This really is quite interesting.
Steve BellMedTech Expert, Former CCOCMR SurgicalIt would bring a great value to our medical robotics offering with MedOS adding a “SW Application layer”, where Kinova traditionally is only offering the “access” to the robot. This would be totally in line with the objective of our Link-M product line of speeding up the time to market while reducing the cost to develop a certified surgical robotic system.
François BoucherVP Strategic GrowthKinovaI’m very excited about the discussion we had on a medical version of ROS. I am eager to discuss ways in which we can contribute to this project. This would lead to increasing autonomous capabilities in medical robotics.
Ron Alterovitz, PhDLawrence Grossberg Distinguished Professor of Computer ScienceUniversity of North CarolinaAs we prepare to launch a surgical robot in India, partnering with Roboss was an easy decision. Their expert team combined with MedOS is without doubt the fastest path to building a complex surgical robot, while retaining full ownership of our IP. In a market where no true one-stop solution existed, Roboss fills that gap entirely. We have a strong intent to collaborate with them, and we are confident they will be central to our journey.
Jiten SurtaniExecutive DirectorAdvanced MedTech Solutions (AMS), IndiaRoboss has extraordinary talent for niche in robotics hardware and software. It’s solving deep tech problem of surgical robotics with its proprietary software which adds deep moat.
Aashish AgarwalDirectorAadxa Robotics Private Limited, IndiaBuilding the next surgical robot?
Let’s talk about how MedOS can accelerate your development.